Dr. Polina Khanina, MD

Dr. Khanina practices at Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System.

Dr. Khanina's NPI, 1285679498, was assigned on June 19, 2006. Dr. Khanina holds New York license 221604.

Dr. Khanina's primary practice is Mount Sinai South Nassau, at One Healthy Way, Oceanside, NY 11572 in Nassau County. The practice phone is (516) 632-3000. Dr. Khanina also practices at South Nassau Communities Hospital, 1 Healthy Way, Oceanside, NY 11572.

Dr. Khanina's primary practice is Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System. Dr. Khanina is also affiliated with St. John's Episcopal Hospital. The medical group on file is Multiviz Health Services. Dmand AI also links Dr. Khanina to 4 more home health agencies, 4 skilled nursing facilities, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khanina practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Khanina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Khanina is licensed in New York.

CMS data shows 9,445 Medicare services from Dr. Khanina across 20 procedure codes in 2024, for 891 Medicare patients. Medicare paid $816,404 for them.

CMS counts 891 Medicare patients who saw Dr. Khanina in 2024. The largest group is 75 to 84, with 326 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khanina's median patient age at 76, with 54% women.

In 2024, Dr. Khanina wrote 31,465 Medicare Part D claims for 952 patients. 78% of them were for generic drugs. CMS names the drug for 30,497 of them, across 290 drugs with 11 or more claims each, at $2,637,535 in total drug cost. In 2023, CMS named 18,490 claims across 233 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Khanina for performance year 2024, reported individually. Dr. Khanina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khanina as offering telehealth.

CMS Open Payments shows 157 general payments to Dr. Khanina from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Smith & Nephew, Inc. paid the most, $497.